The NHS fast-track the introduction of 'game changing' new cancer drugs The NHS is to fast-track the introduction of 'game changing' new cancer drugs that target tumours according to their genetic make-up.
Tumour agnostic drugs can treat a wide range of cancers regardless of where they originate, such as the breast or lungs.
They work by blocking an enzyme which helps the tumour to grow. In trials, 75 per cent of tumours responded.
Children are expected to benefit the most, as well as those with rare cancers who don't have many treatment options. The Daily Mail
See also:
Tumour agnostic drugs can treat a wide range of cancers regardless of where they originate, such as the breast or lungs.
They work by blocking an enzyme which helps the tumour to grow. In trials, 75 per cent of tumours responded.
Children are expected to benefit the most, as well as those with rare cancers who don't have many treatment options. The Daily Mail
See also:
No comments:
Post a Comment